Science 37 (NASDAQ:SNCE – Get Rating) had its price target reduced by equities research analysts at Cowen from $7.00 to $3.00 in a research note issued on Monday, The Fly reports. The firm currently has an “outperform” rating on the stock. Cowen’s price objective points to a potential upside of 256.55% from the stock’s current price.
A number of other research analysts have also recently weighed in on SNCE. Craig Hallum dropped their price target on Science 37 to $7.00 in a research report on Monday, August 15th. Robert W. Baird dropped their price target on Science 37 from $6.00 to $2.00 in a research report on Friday, November 11th. Finally, Cowen dropped their price target on Science 37 to $7.00 in a research report on Monday, August 15th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $7.00.
Science 37 Stock Performance
Science 37 stock opened at $0.84 on Monday. Science 37 has a one year low of $0.81 and a one year high of $14.44. The business has a fifty day moving average of $1.50 and a two-hundred day moving average of $2.19. The company has a market cap of $98.16 million, a P/E ratio of -1.68 and a beta of 1.27.
Institutional Trading of Science 37
Science 37 Company Profile
Science 37 Holdings, Inc provides technology-based solutions to enable agile clinical trials and decentralized approaches. Its platform enables modern and digital approaches to clinical research by bringing together all parties, including the patient and trial investigators, nurses, coordinators, and sponsors to power workflows, centralize evidence generation, and harmonize data.
- Get a free copy of the StockNews.com research report on Science 37 (SNCE)
- Power Integrations Stock Can Power Your Portfolio
- Don’t Chase Walmart Higher, Wait For Extra Low Prices
- Home Depot Results (and Institutions) Are A Catalyst For Lowe’s?
- Agilent Remains In Buy Range Ahead Of Next Week’s Q4 Report
- Three Penny Stocks Making Big Moves In November
Receive News & Ratings for Science 37 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Science 37 and related companies with MarketBeat.com's FREE daily email newsletter.